34764759|t|Neuroprotective efficacy of 4-Hydroxyisoleucine in experimentally induced intracerebral hemorrhage.
34764759|a|Intracerebral hemorrhage (ICH) is a severe form of brain injury, which is a major cause of mortality in humans. Hydrocephalus and cerebral hematoma lead to severe neurological deficits. A single autologous blood (ALB) injection in rats' brains induces hemorrhage and other conditions that regularly interfere with the standard treatment of several cellular and molecular pathways. Several studies have found that IGF-1/GLP-1 decreases the production of inflammatory markers in peripheral tissues, while some have found that they also have pro-inflammatory functions. Since these receptors are down-regulated in hemorrhagic situations, we looked into the potential neuroprotective effect of 4-hydroxyisoleucine (4-HI); 50 mg/kg and 100 mg/kg, an active compound Trigonellafoenum-graecum, on post-hemorrhagic deficits in rats. Long-term oral administration of 4-HI for 35 days has improved behavioral and neurochemical deficits and severe pathological changes and improved cellular and molecular markers, apoptotic markers in the ALB-induced ICH experimental model. Furthermore, the findings revealed that 4-HI also improved the levels of other neurotransmitters (Ach, DOPA, GABA, glutamate); inflammatory cytokines (TNF-alpha, IL-1beta, IL-17), and oxidative stress markers (MDA, nitrite, LDH, AchE, SOD, CAT, GPx, GSH) in the brain when evaluated after Day 35. There is no proven treatment available for the prevention of post-brain hemorrhage and neurochemical malfunction; available therapy is only for symptomatic relief of the patient. Thus, 4-HI could be a potential clinical approach for treating post-brain haemorrhage and neurochemical changes caused by neurological damage. Furthermore, 4-HI may be linked to other standard therapeutic therapies utilized in ICH as a potential pharmacological intervention.
34764759	28	47	4-Hydroxyisoleucine	Chemical	MESH:C104672
34764759	74	98	intracerebral hemorrhage	Disease	MESH:D002543
34764759	100	124	Intracerebral hemorrhage	Disease	MESH:D002543
34764759	126	129	ICH	Disease	MESH:D002543
34764759	151	163	brain injury	Disease	MESH:D001930
34764759	204	210	humans	Species	9606
34764759	212	225	Hydrocephalus	Disease	MESH:D006849
34764759	230	247	cerebral hematoma	Disease	MESH:D020202
34764759	263	284	neurological deficits	Disease	MESH:D009461
34764759	331	335	rats	Species	10116
34764759	352	362	hemorrhage	Disease	MESH:D006470
34764759	513	518	IGF-1	Gene	24482
34764759	519	524	GLP-1	Gene	24952
34764759	553	565	inflammatory	Disease	MESH:D007249
34764759	643	655	inflammatory	Disease	MESH:D007249
34764759	711	722	hemorrhagic	Disease	MESH:D006470
34764759	790	809	4-hydroxyisoleucine	Chemical	MESH:C104672
34764759	811	815	4-HI	Chemical	MESH:C104672
34764759	861	885	Trigonellafoenum-graecum	Species	78534
34764759	890	894	post	Disease	MESH:D000094025
34764759	895	915	hemorrhagic deficits	Disease	MESH:D006474
34764759	919	923	rats	Species	10116
34764759	958	962	4-HI	Chemical	MESH:C104672
34764759	1003	1025	neurochemical deficits	Disease	MESH:D009461
34764759	1140	1143	ICH	Disease	MESH:D002543
34764759	1204	1208	4-HI	Chemical	MESH:C104672
34764759	1262	1265	Ach	Chemical	MESH:D000109
34764759	1267	1271	DOPA	Chemical	MESH:D004295
34764759	1273	1277	GABA	Chemical	MESH:D005680
34764759	1279	1288	glutamate	Chemical	MESH:D018698
34764759	1291	1303	inflammatory	Disease	MESH:D007249
34764759	1315	1324	TNF-alpha	Gene	24835
34764759	1326	1334	IL-1beta	Gene	24494
34764759	1336	1341	IL-17	Gene	301289
34764759	1374	1377	MDA	Chemical	MESH:D015104
34764759	1379	1386	nitrite	Chemical	MESH:D009573
34764759	1393	1397	AchE	Gene	83817
34764759	1404	1407	CAT	Gene	24248
34764759	1414	1417	GSH	Chemical	MESH:D005978
34764759	1522	1526	post	Disease	MESH:D000094025
34764759	1527	1543	brain hemorrhage	Disease	MESH:D020300
34764759	1631	1638	patient	Species	9606
34764759	1646	1650	4-HI	Chemical	MESH:C104672
34764759	1703	1725	post-brain haemorrhage	Disease	MESH:D006474
34764759	1762	1781	neurological damage	Disease	MESH:D020196
34764759	1796	1800	4-HI	Chemical	MESH:C104672
34764759	1867	1870	ICH	Disease	MESH:D002543
34764759	Positive_Correlation	MESH:C104672	MESH:D005680
34764759	Positive_Correlation	MESH:C104672	MESH:D005978
34764759	Negative_Correlation	MESH:D007249	24482
34764759	Negative_Correlation	MESH:C104672	MESH:D020196
34764759	Positive_Correlation	MESH:C104672	301289
34764759	Positive_Correlation	MESH:C104672	MESH:D009461
34764759	Negative_Correlation	MESH:C104672	MESH:D007249
34764759	Negative_Correlation	MESH:D007249	24952
34764759	Positive_Correlation	MESH:C104672	MESH:D015104
34764759	Negative_Correlation	MESH:C104672	MESH:D002543
34764759	Positive_Correlation	MESH:C104672	MESH:D004295
34764759	Positive_Correlation	MESH:C104672	24248
34764759	Association	MESH:C104672	83817
34764759	Negative_Correlation	MESH:C104672	MESH:D006474
34764759	Positive_Correlation	MESH:C104672	MESH:D009573
34764759	Negative_Correlation	MESH:C104672	24835
34764759	Positive_Correlation	MESH:C104672	MESH:D018698
34764759	Positive_Correlation	MESH:C104672	24494
34764759	Positive_Correlation	MESH:C104672	MESH:D000109

